A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder

Clinical trial NCT02045862 · COMPLETED

Trial details

NCT number: NCT02045862
Sponsor: Astellas Pharma Europe B.V.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Urinary Bladder Overactive Overactive Bladder Urgency Incontinence Urinary Bladder Diseases\Urologic Diseases

Start date: 2014-03-17
Primary completion: 2016-09-08
Enrollment: 1829

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.